D.I. Trukhan, D.S. Ivanova
Drug safety in real clinical practice: focus on protective therapy
|
№3 / 2022
|
P.S. Laguta
ACETYLSALICYLIC ACID AND PRIMARY PREVENTION: NEW OPPORTUNITIES
|
№15 / 2017
|
A.V. Melekhov
LONG-TERM USE OF ASPIRIN: POSSIBLITIES OF OPTIMIZATION
|
№18 / 2016
|
I.V.Holkin; D.F. Khusainova, L.A.Sokolova, E.V.Anikin
Role Of Early Antiplatelet Therapy In Acute Coronary Syndromes Without St-segment Elevation At The Pre-hospital Stage
|
№20 / 2012
|
P.R. Kamchatnov, S.G. Zhdanov
Secondary Prevention Of Ischemic Stroke - A Place Of Antiplatelet Therapy
|
№20 / 2011
|
M.Yu. Gilyarov
Place Of Aspirin In The Therapy Of Atherothrombosis And Its Complications
|
№15 / 2011
|
V.V. Fomin, V.V. Panasyuk
Features Of Management Of Elderly Patients With Acute Myocardial Infarction
|
№13 / 2010
|
G.Tabeeva
Discirculatory Encephalopathy: The Main Targets Of Therapy
|
№5 / 2010
|
P.S. Laguta
Acetylsalicylic Acid In The Treatment And Prophylaxis Of Cardio-vascular Diseases: Issues Of Efficacy And Safety
|
№12 / 2009
|